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ABSTRACT 29 
Chronic wounds pose an increasingly significant worldwide economic burden (over 30 
£1 billion per annum in the UK alone).  With the escalation in global obesity and 31 
diabetes, chronic wounds will increasingly be a significant cause of morbidity and 32 
mortality.  Cellulose nanofibrils (CNF) are highly versatile and can be tailored with 33 
specific physical properties to produce an assortment of three-dimensional structures 34 
(hydrogels, aerogels or films), for subsequent utilization as wound dressing materials.  35 
Growth curves using CNF (diameter <20 nm) in suspension demonstrated an 36 
interesting dose-dependent inhibition of bacterial growth.  In addition, analysis of 37 
biofilm formation (Pseudomonas aeruginosa PAO1) on nanocellulose aerogels (20 38 
g/m2) revealed significantly less biofilm biomass with decreasing aerogel porosity and 39 
surface roughness.  Importantly, virulence factor production by P. aeruginosa in the 40 
presence of nanocellulose materials, quantified for the first time, was unaffected 41 
(p>0.05) over 24 h.  These data demonstrate the potential of nanocellulose materials 42 
in the development of novel dressings that may afford significant clinical potential. 43 
 44 
 45 
  46 
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1. Introduction 47 
Normal wound healing follows a defined process involving; coagulation, 48 
inflammation, cell proliferation, matrix repair, epithelialization and remodeling 49 
(Bjarnsholt et al., 2008).  In contrast, chronic wounds are typically characterized by 50 
elevated inflammatory responses and tissue breakdown, and are slow or fail to heal, 51 
causing a considerable reduction in patient ‘quality-of-life’.  With a globally ageing 52 
population, the biomedical and socioeconomic burdens of chronic wounds are 53 
worsening, with annual costs in the US estimated at > $50 billion per annum and 54 
affecting 6.5 million people (2% of the population) (Jung et al., 2016).  Chronic 55 
wounds are always colonized with bacteria, and the pathogen Pseudomonas 56 
aeruginosa is implicated in non-healing wounds (Davies et al., 2004).  The ability of 57 
these opportunistic pathogens to produce a thick, mucoid wound biofilm is thought to 58 
prevent an effective response by host immune defenses, thereby impairing wound 59 
healing (Percival et al., 2012).  60 
The most abundant naturally-occurring polymer is cellulose, which can be 61 
obtained from a variety of sources including: wood, non-woody plants, agricultural 62 
residues, algae and bacteria.  In addition to bacterial cellulose (Czaja, Krystynowicz, 63 
Bielecki & Brown, 2006; Petersen & Gatenholm, 2011; Portal, Clark & Levinson, 64 
2009), nanocellulose from wood pulp has been proposed as an appropriate material 65 
for wound dressing applications (Chinga-Carrasco & Syverud, 2014; Powell et al., 66 
2016; Rees et al., 2015).  Nanocellulose can be produced in large quantities using 67 
effective chemical pre-treatments, which facilitate deconstruction of the wood fiber 68 
wall into cellulose nanofibrils (CNF) (Chinga-Carrasco & Syverud, 2014; Saito, 69 
Nishiyama, Putaux, Vignon & Isogai, 2006; Wågberg et al., 2008).  TEMPO-70 
mediated oxidation is one of the most applied procedures for CNF production, leading 71 
to the introduction of carboxyl groups in the C6 position and small numbers of 72 
aldehyde groups (Saito & Isogai, 2004; Saito et al., 2006).  TEMPO-mediated 73 
oxidation produces morphologically homogeneous CNF, having diameters less than 74 
20 nm and lengths in the micrometer scale (Chinga-Carrasco, Yu & Diserud, 2011; 75 
Saito & Isogai, 2004).  Furthermore, this material can be used to produce an 76 
assortment of three-dimensional structures e.g. strong, dense and smooth films 77 
(Fukuzumi, Saito, Iwata, Kumamoto & Isogai, 2009) and structured hydrogels and 78 
aerogels with high porosity, with capacity to absorb large quantities of moisture 79 
(Chinga-Carrasco & Syverud, 2014; Syverud, Kirsebom, Hajizadeh & Chinga-80 
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Carrasco, 2011).  We recently developed a method to produce CNF from P. radiata 81 
fibers, with low endotoxin levels (<50 endotoxin units/g cellulose) (Nordli, Chinga-82 
Carrasco, Rokstad & Pukstad, 2016) and demonstrated that TEMPO CNF exhibits no 83 
toxicity towards 3T3 cells (Alexandrescu, Syverud, Gatti & Chinga-Carrasco, 2013) 84 
and primary human skin cells i.e. fibroblasts or keratinocytes (Nordli et al., 2016; 85 
Tehrani, Nordli, Pukstad, Gethin & Chinga-Carrasco, 2016).  These studies suggested 86 
the potential of these materials for wound dressing applications (Nordli et al., 2016).   87 
With the increasing economic burden chronic wounds are placing on 88 
worldwide healthcare systems, the use of non-toxic, biodegradable biopolymers from 89 
an abundant, sustainable source, such as wood CNF, for wound healing applications 90 
would be a distinct advantage in our current ‘throw-away’ culture.  Many 91 
commercially available wound dressings possess a high capacity to absorb moisture 92 
due to their porous, three-dimensional structure.  However, little attention has been 93 
paid of the effect of CNF materials (also with high moisture absorption capabilities) 94 
on biofilm formation of typical wound pathogens.   95 
This study assessed (i) the effect of CNF hydrogels, at varying concentrations 96 
of CNF dispersion, on Pseudomonas aeruginosa (PAO1) growth in suspension, (ii) 97 
the effect of surface and bulk structure of CNF dressings on biofilm formation of 98 
PAO1 and, (iii) for the first time, the effects of these porous structures on 99 
pseudomonal virulence factor production. 100 
 101 
2. Materials and Methods 102 
2.1. CNF production 103 
Pinus radiata pulp fibers were used as the raw material for CNF production.  104 
The carbohydrate composition of the pulp fibers has previously been reported 105 
(Chinga-Carrasco et al., 2012).  TEMPO (2,2,6,6-tetramethylpiperidinyl-1-oxyl) 106 
mediated oxidation was applied as a pretreatment, using 3.8 mM NaClO/g cellulose, 107 
pH 10.5 (Saito et al., 2006).  Oxidized fibers (1% w/v) were fibrillated following 108 
three passes through a Rannie 15 type 12.56X homogenizer.  The degree of 109 
polymerization (DP 709), aldehyde groups (71 /g) and carboxyl groups (855 110 M/g) have previously been quantified (Rees et al., 2015). 111 
 112 
 113 
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2.2. Sample Preparation 114 
CNF samples were air- or freeze-dried to produce tight (films) or porous 115 
structures (aerogels), respectively.  Freeze-dried samples were prepared at 0.2, 0.4 or 116 
0.6% (w/v) CNF dispersions, frozen in petri dishes at -20ºC and freeze-dried for 48 h.  117 
Although differing CNF concentrations were used in the liquid dispersions, the actual 118 
grammage for all the resulting dried films and aerogels was 20 g/m2.  All the samples 119 
were cut into 1 or 2 cm2 sections and sterilized by γ-irradiation (15 kGy).  120 
Commercially-available wound dressings AquaCel® and AquaCel Ag® (ConvaTec 121 
Ltd, Deeside) were used as controls. 122 
 123 
2.3. Absorption Measurements   124 
Fluid absorption of the test and control materials was assessed as previously 125 
described (Fulton et al., 2012).  Dressing materials were cut into 1 cm2 squares and 126 
weighed to the nearest 0.001 g.  Samples were submerged in phosphate buffer saline, 127 
pH 7.4 (PBS) for 24 h, covered to prevent evaporation.  Samples were then removed 128 
from the PBS and allowed to drip for 30 s and a wet weight obtained.  Fluid 129 
absorption (g/g) = weight of the fluid absorbed/dressing dry weight.   130 
 131 
2.4. Taxonomy of the samples 132 
The varying percentages of CNF (wet weight) accounted for varying degrees of 133 
porosity in the dried materials.  Once dried, there was no difference in the 134 
concentration of CNF incorporated in each of the prototype samples (20 g/m2; Table 135 
1). 136 
 137 
Table 1 138 
Characteristics of the nanocellulose (CNF) materials used in this study. 139 
Sample name Concentration of CNF 
dispersion (w/v) 
Sample preparation      
(resulting material)a 
A0.2 0.2% Freeze-dried (aerogel) 
A0.4 0.4% Freeze-dried (aerogel) 
A0.6 0.6% Freeze-dried (aerogel) 
Film 0.2%  Air-dried (film) 
aGrammage of  all final dried materials = 20 g/m2 140 
  141 
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2.5.Screening for the ability of CNF to support bacterial growth.   142 
Bacterial growth and carbon utilization studies were undertaken using CNF 143 
dispersions.  CNF dispersions were sterilized by γ-irradiation, and then diluted in 144 
deionized sterilized water to a final CNF concentration of 0.2, 0.4, 0.6 and 0.8%.  The 145 
ability of CNF to inhibit or promote growth of P. aeruginosa PAO1 in planktonic 146 
culture was examined.  Overnight cultures of PAO1 were diluted to OD600 0.08 147 
(colony forming units = 1 x108) in either MH broth, PBS or deionized water, and 148 
mixed 1:2 (v/v) with CNF dispersion or water in a 24 well plate.  Plates were 149 
incubated at 37⁰C aerobically for 24 h measuring OD600 every hour at 600 nm (OD600) 150 
in a FLUOstar Optima plate reader (BMG LABTECH). 151 
 152 
2.6. Log10 reduction assay  153 
 Time kill assays adapted from Ong, Wu, Moochhala, Tan, & Lu (2008) were 154 
used to evaluate the antimicrobial efﬁcacy of aerogel and film materials in 155 
comparison to a commercially available wound dressing (AquaCel®) control.  CNF 156 
samples or AquaCel (Ag)® were added to a 6-well plate; 2×2 cm2 per well in total.  157 
MH-broth (6 ml) and 60 µl of PAO1 overnight culture adjusted to OD600 1.0 were 158 
then added to each well.  Plates were incubated at 37⁰C, 24 h (aerobically), with 159 
shaking.  To enumerate bacterial growth, 10 µl drops (3 x 10 µl per dilution) of 160 
bacterial suspension was removed from each dilution and dropped onto the surface of 161 
an MH-agar plate.  The drops were air-dried before being incubated overnight at 37ºC 162 
to enumerate colony forming units (CFU/ml).  Log reduction was calculated as log10 163 
CFU/ml (initial bacteria upon challenge) minus log10 CFU/ml (surviving bacteria at 164 
time point after challenge).  Bactericidal activity was deﬁned as a ≥3 log10 CFU/ml 165 
(equivalent to ≥99.9%) reduction in bacterial numbers. 166 
 167 
2.7. Assessment of virulence factors 168 
 Overnight cultures of P. aeruginosa PAO1 were adjusted to OD600 1.0, and 60 µl 169 
were added to MH-broth (6 ml) in a 6-well plate and grown for 24 h ± CNF samples 170 
or AquaCel (Ag)® (2×2 cm2).  Bacterial cultures were then centrifuged (10000 g) for 171 
10 min to produce a cell-free culture supernatant, used for extraction of virulence 172 
factors.  173 
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 Pyocyanin pigment was extracted from the cell-free supernatant using chloroform 174 
(3:2; v/v).  Pyocyanin (in the chloroform-phase) was re-extracted with 0.2 M HCl 175 
(2:1; v/v) and the absorbance read at 540 nm (Sarabhai, Sharma & Capalash, 2013). 176 
 Rhamnolipids were extracted from the cell-free supernatant using ethyl acetate 177 
(1:1, v/v), vortexed for 15 sec and centrifuged (10000 g, 4ºC, 5 min).  The top layer 178 
was removed and the extraction repeated (x2) before allowing the ethyl acetate to 179 
evaporate overnight.  Deionized water was used to dissolve the precipitate and orcinol 180 
reagent (0.19% orcinol in 53% H2SO4; 1:9, v/v) added.  The sample was incubated at 181 
80ºC for 30 min before reading the absorbance at 421 nm (Smyth, Perfumo, McClean, 182 
Marchant & Banat, 2010). 183 
 Protease activity was determined using 2% azocasein solution in 50 mM PBS, pH 184 
7.  The azocasein solution was incubated with the cell-free supernatant (1:1; v/v) in a 185 
total reaction volume of 400 µl, for 1 h at 37 ºC.  The reaction was stopped by the 186 
addition of 500 µl 10% trichloroacetic acid, and residual azocasein removed by 187 
centrifugation (8000 g, 5 min).  Protease absorbance was measured at 400 nm 188 
(Adonizio, Kong & Mathee, 2008). 189 
 For elastase determination, cell-free supernatant was mixed (3:1; v/v) with 190 
elastin-congo-red solution (5 mg/ml in 0.1 M Tris-HCl pH 8; 1 mM CaCl2).  Samples 191 
were incubated at 37 ºC, for up to 16 h, at 200 rpm, centrifuged at 3000 g (10 min) 192 
before absorbance was read at 490 nm (Sarabhai et al., 2013). 193 
 194 
2.8. Microscopy characterization of CNF structures 195 
Copper grids were immersed in a 0.01% suspension of the CNF sample and 196 
stained with uranyl acetate.  Scanning Transmission Electron Microscopy (STEM) 197 
using a Hitachi S-5500 electron microscope was used to acquire images in bright field 198 
mode (x150000 magnification), using an acceleration voltage of 30 kV. 199 
AFM imaging (tapping mode) of the film sample was performed with a 200 
Multimode AFM with Nanoscope V controller, (Digital Instruments) and images were 201 
acquired in ScanAsyst mode at room temperature.  The AFM tips of spring constant 202 
value ~0.4 N/m were purchased from Bruker AFM probes.  The image size was 2 µm 203 
x 2 µm, with a resolution of 1.95 nm/pixel. 204 
The aerogels and films were freeze-dried for SEM analysis.  Cross-sections of 205 
the films and aerogels were prepared by ion milling (using an IM4000 system), where 206 
the milling time was 5 hours at 2.5 kV.  In addition, samples were cut from the 207 
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aerogels and films using an 8 mm punch biopsy for surface analysis.  All samples 208 
were sputter-coated with gold and images acquired using a Hitachi scanning electron 209 
microscope (SEM, SU3500), in secondary electron imaging mode. 210 
 211 
2.9. Confocal laser scanning microcopy (CLSM) and scanning electron microscopy 212 
(SEM) of biofilm growth on CNF materials  213 
 CNF samples (1 cm2) were added to a 12-well plate to which contained MH broth 214 
(3 ml) and 60 µl of PAO1 overnight culture adjusted to OD600 0.4.  Plates were 215 
incubated at 37ºC in a static aerobic environment for 24 or 48 h before removing the 216 
supernatant and then washing the biofilms once with deionised water/PBS.  Biofilms 217 
were stained with LIVE/DEAD® BacLight™ bacterial viability kit (Invitrogen, 218 
Paisley, UK) containing SYTO 9 dye (staining LIVE cells, green) and propidium 219 
iodide (staining DEAD cells, red) and incubated in the dark (10 min) before mounting 220 
on microscope slides with spacers, being set in Vectorshield (Vector Laboratories, 221 
UK) and having a coverslip on top, sealed with nail varnish.  Biofilms were imaged 222 
with a Leica TCS SP2 confocal system (x63).  Bacterial growth was quantified using 223 
COMSTAT image-analysis software (Heydorn et al., 2000). 224 
   Biofilm samples were prepared for SEM analyses by immersion in 225 
glutaraldehyde (2.5%) for 24 h, before being washed with deionised water (x4) and 226 
immersed in fresh deionised water, and then frozen (24 h) and freeze-dried for 24 h.  227 
The biofilms were then imaged on the Tescan Vega SEM at 5 kV.  Additionally, the 228 
A0.6 aerogel with PAO1 biofilm growth was also ion-milled (as described above) and 229 
SEM images acquired in secondary electron imaging mode. 230 
 231 
2.10. Statistical analysis   232 
GraphPad Prism 3 was used to perform statistical analysis (GraphPad software Inc, La 233 
Jolla, USA) including one-way ANOVA using Tukey-Kramer post-test (growth curve 234 
data and COMSTAT data) and Dunnet’s multiple comparison tests (log10 reduction 235 
and virulence data).  P<0.05 was considered significant. 236 
 237 
3. Results 238 
3.1. Growth of P. aeruginosa PAO1 in CNF hydrogel suspensions   239 
Irradiated CNF samples at ≥0.4% concentrations indicated dose-dependent 240 
inhibition of P. aeruginosa PAO1 (Fig. 1), possibly reflecting increased viscosity of 241 
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these dispersions or direct inhibition by CNF.  No change in optical density was 242 
observed for CNF in either PBS or water after 24 h, indicating P. aeruginosa did not 243 
grow in, nor could it utilize CNF as a carbon source; growth only being observed in 244 
the presence of MH broth (Fig. S1). 245 
 246 
Fig. 1.  Growth characteristics for P. aeruginosa PAO1 in CNF.  P. aeruginosa PAO1 247 
grown in either MH-broth/dH2O or MH-broth/-irradiated CNF (adjusted to give final 248 
concentrations of CNF at 0.2, 0.4, 0.6 or 0.8%). (n=3).  249 
 250 
3.2. Characterization of the Cellulose Materials 251 
The CNF material was highly fibrillated and structurally homogenous (Rees et 252 
al., 2015), containing CNF with diameters in the nanoscale (<20 nm) and with a high 253 
aspect ratio, as exemplified in this study (Fig. 2). 254 
The aerogel, A0.2 (manufactured from a 0.2% CNF dispersion) possessed the 255 
largest thickness, porosity and surface roughness, as demonstrated by SEM and fluid 256 
absorption (Fig. 3A; Table S1).  The porosity and surface roughness of the other 257 
aerogels decreased with the increasing CNF concentration; A0.6 (manufactured from 258 
a 0.6% CNF dispersion) showing the lowest (Figs 3A-C).  In contrast, the film was far 259 
more dense and extremely thin, with no apparent porosity (Fig. 3D).  The commercial 260 
dressings AquaCel® and AquaCel Ag® displayed rough surfaces, which during the 261 
course of the experiment altered, following fluid absorption. The more porous 262 
(thicker) CNF aerogels absorbed more moisture when compared to the film; 263 
resembling absorbancy of AquaCel® and AquaCel Ag®. 264 
 265 
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 266 
Fig. 2.  Highly fibrillated nanocellulose.  (A) Atomic force microscopy imaging 267 
(AFM).  (B) Scanning Transmission Electron Microscopy imaging (STEM).  Arrows 268 
indicate individual nanofibrils. 269 
 270 
 271 
Fig. 3.  Scanning electron microscopy of aerogels and films (cross-sectional and 272 
aerial views) made with CNF.  (A) A0.2.  (B) A0.4.  (C) A0.6.  (D) Film.  Arrows 273 
indicate local thickness of the materials. (N.B. A0.2 was too thick to be visualized in 274 
its entirety within the maximum field of view).   275 
 276 
3.3 Log10 reduction assay 277 
The ability of CNF films and aerogels (with differing porosities) to inhibit the 278 
growth of planktonic P. aeruginosa PAO1 showed that none of the CNF materials, 279 
(both aerogels, 0.29-0.37±0.33-0.37 and film samples, 0.25±0.21) demonstrated 280 
significant change in Log10 CFU, being comparable to the negative controls 281 
AquaCel® dressing (0.24±0.16) and MH (0.38±0.37).  AquaCel Ag® (the positive 282 
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control) containing ionic silver however, demonstrated significant bactericidal activity 283 
(≥3 log-fold) reduction in Log10 CFU compared to the control (6.62±0.94).  284 
 285 
3.4. Virulence factor assays 286 
The production of virulence factors (pyocyanin, rhamnolipids, total proteases and 287 
elastase) by P. aeruginosa PAO1 was not affected by CNF (Fig. 4).  However, for 288 
elastase (measured at 1, 3 and 8 h) a significant difference to the control was 289 
detectable at ≥3 hours of incubation.  A modest decreasing trend in pyocyanin 290 
production was noted based on the porosity of the aerogel materials, with A0.2 291 
(largest pores, Fig. 3A) producing the greatest amount, whereas the A0.6 (smallest 292 
pores, Fig. 3C) and film (no pores at the assessed scale) produced the least, however 293 
this was found not to be significant.   294 
 295 
 296 
Fig. 4. The effect of the different CNF film and aerogels on virulence factor 297 
production by Pseudomonas aeruginosa PAO1 (A) pyocyanin.  (B) rhamnolipid.  (C)  298 
total protease.  (D) elastase, when compared to the negative controls MH broth and 299 
AquaCel Ag®.  (*significantly different as compared to the PAO1 control; n=3; 300 
p<0.05).    301 
 302 
 303 
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3.5. Confocal Laser Scanning Microscopy (CLSM) 304 
P. aeruginosa PAO1 was able to form established biofilms on all the CNF and 305 
commercial (AquaCel®-based) dressing materials (Fig. 5, and Fig. S2 in the 306 
supporting information) at 24 and 48 h.  LIVE/DEAD®-staining confirmed bacterial 307 
viability in the established biofilms.  Little difference in bacterial viability was 308 
evident for all the dressings, (apart from AquaCel Ag® which showed sparse biofilm 309 
growth at 24 h).  COMSTAT image analysis was employed to quantify biomass, 310 
surface roughness (using a roughness coefficient) and mean biofilm thickness (Fig. 5 311 
and Fig. S2) in test samples and control Aquacel Ag®.   312 
 313 
 314 
 315 
Fig. 5. CLSM images and COMSTAT analysis of LIVE/DEAD® staining of 24 h 316 
biofilms grown on CNF aerogels A0.2, A0.4 and A0.6 (0.2, 0.4 and 0.6% 317 
respectively), film and commercial dressings (Aquacel and Aquacel Ag) showing 318 
mean:  (A) biomass;  (B) thickness  and (C) roughness coefficient (n=3, *p>0.001).  319 
All materials were significantly different to Aquacel Ag (data not shown on graphs). 320 
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COMSTAT analysis (n=7 images from n=3 replicates) revealed the viability of 321 
the biofilms and that a distinct decrease in viable cell numbers was observed between 322 
24 and 48 h, (Fig. 5A and Fig. S2A in the supporting information).  In the aerogels, 323 
biomass reflected material porosity; the greatest biomass being observed in A0.2 and 324 
decreased to A0.6 (the least porous aerogel; p<0.05).  AquaCel Ag® had very little 325 
growth at both 24 and 48 h, reflecting the CLSM.   326 
Biofilm thickness varied between samples tested, although at 24 h these 327 
differences were less apparent (Fig. 5B).  As expected, mean thickness was higher on 328 
all the materials compared to AquaCel Ag® (Fig. 5B and Fig. S2B in the supporting 329 
information), with differences more apparent at 48 h.  330 
There were significant differences in roughness coefficient between biofilms 331 
grown on the different materials, with biofilms grown on A0.2 being the roughest, 332 
while biofilms grown on A0.6 and Film were significantly smoother (p<0.05; 24 h); 333 
AquaCel Ag® being the roughest of all at both 24 and 48 h (Fig. 5C and Fig. S2C in 334 
the supporting information).  Generally, at 48 h there were less distinguishable 335 
differences between surface roughness, probably reflecting the large proportion of 336 
non-viable cells present on all the materials at this time.  337 
 338 
 339 
Fig. 6. SEM image of cross-section following ion milling of a P. aeruginosa biofilm 340 
growing on the A0.6 aerogel.  341 
 342 
3.6.Scanning electron microscopy (SEM) of biofilm growth on CNF materials.   343 
SEM imaging of a cross-section through a CNF aerogel following ion milling 344 
confirmed that a large part of the biofilms were formed inside the aerogel structure 345 
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(Fig. 6), probably due to the relatively large porosity of the samples.  SEM imaging of 346 
the surface of the materials can be found in Figs. S3-S6 in the supporting information. 347 
 348 
4. Discussion 349 
It has become increasingly recognized that chronic wounds are able to sustain 350 
a substantial bacterial biofilm which (both directly and indirectly) influences clinical 351 
outcome (Hill et al., 2010).  The CNF materials did not support bacterial growth of 352 
Pseudomonas aeruginosa PAO1, confirming that the CNF could not be used as a 353 
bacterial carbon source by the wound pathogen PAO1 (Powell et al., 2016).  Materials 354 
that significantly impair microbial growth would be a distinct advantage for a wound 355 
dressing and, interestingly, a dose-dependent inhibition of bacterial growth by the 356 
CNF hydrogel was evident.  This inhibition may, in part, reflect the apparent viscosity 357 
of the medium, as motile species, such as P. aeruginosa, move through media 358 
obtaining available nutrients (Sampedro, Parales, Krell & Hill, 2015).  In keeping 359 
with this notion, the Log10 reduction assay revealed that CNF aerogels and films 360 
failed to inhibit microbial planktonic growth of P. aeruginosa PAO1 in these studies 361 
(as did the commercial wound dressing AquaCel®).  The CNF materials may, 362 
therefore, exhibit distinct properties in hydrogel, aerogel or film forms.  363 
P. aeruginosa PAO1 produces the blue pigment, pyocyanin, which is a 364 
secondary metabolite that interrupts cellular function and is also a virulence factor 365 
(Lau, Hassett, Ran & Kong, 2004) affecting mammalian cells by inhibiting cell 366 
respiration and ciliary function (Ran, Hassett & Lau, 2003; Sorensen & Klinger, 367 
1987).  Rhamnolipids are also virulence factors produced by P. aeruginosa which aid 368 
colonisation by acting as a surfactant, reducing surface and interfacial tension 369 
(Soberón-Chávez, Lépine & Déziel, 2005).  In addition, the production of 370 
rhamnolipids in P. aeruginosa can enable the utilization of alternative carbon sources 371 
(such as alkanes) by pseudosolubilisation of insoluble substrates that would not 372 
normally be broken-down (Beal & Betts, 2000).  P. aeruginosa also secretes proteases 373 
and elastase that have been implicated as virulence factors (Caballer et al., 2001), 374 
both of which are known to damage dermal matrix proteins and hinder cell migration 375 
and wound healing (Oldal & Tranfny, 2005).  The lack of effect of CNF wound 376 
dressing materials on these virulence factors was characterized for the first time in the 377 
present study.  378 
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Wound dressings represent, not only a physical barrier to infection and 379 
trauma, but also incorporate antimicrobials to inhibit bacterial growth and provide an 380 
optimal (moist) environment to facilitate wound healing (i.e. cell proliferation, 381 
migration and differentiation).  In close proximity to damaged skin, for considerable 382 
periods of time, they must be biocompatible.  A number of natural polymers are 383 
already used as dressing materials including polysaccharides e.g. alginates and 384 
chitins, and proteins e.g. collagen (Mogoşanu & Grumezescu, 2014).  Unlike bacterial 385 
nanocellulose, CNF has not traditionally been used for biomedical applications (Lin 386 
& Dufresne, 2014).  Whilst a number of researchers have investigated CNF 387 
interactions in immune/inflammatory responses (Hua et al., 2015; Nordli et al., 2016), 388 
as scaffolds for cell culture (Lou et al., 2014; Ninan et al., 2013) and as spray-dried 389 
coatings (or stabilisers) for tablet production (Kolakovic et al., 2011), few have 390 
studied their interaction with the bacteria and biofilms which characterize human 391 
infection.  This study clearly advances our previous studies with nanocellulose for 392 
wound dressings (Nordli et al., 2016; Powell et al., 2016), and represents novel 393 
findings in this area.   394 
TEMPO-mediated oxidization of fibers is used to facilitate breakage of native 395 
hydrogen bonding of individual cellulose fibrils from wood cellulose fibers without 396 
causing extensive damage to the materials which would otherwise occur (Isogai, Saito 397 
& Fukuzumi, 2011).  This chemical pre-treatment is followed by physical 398 
homogenization of the materials; the fibrillation process determining the 399 
characteristics of the resulting material, i.e. fibril size.  This resultant uniform, highly-400 
fibrillated material is suitable for a range of medical applications and may be 401 
functionalized/modified in individual biomedical applications (Lin & Dufresne, 402 
2014).  An important consideration for clinical use is sterility.  The lack of structural 403 
changes in aerogels and films following γ-irradiation reflects its suitability for large-404 
scale manufacturing/processing.  The recent demonstration confirming that ultrapure 405 
CNF (lipopolysaccharide content <50 endotoxin units/gram cellulose) meets the 406 
endotoxin limits required in medical devices for wound management (Nordli et al., 407 
2016), was also reassuring. 408 
Three-dimensional visual assessment of the CNF CLSM images proved 409 
difficult and subjective due to the inherently rough surfaces and heterogeneous nature 410 
of the biofilms which formed.  COMSTAT image analysis was therefore employed to 411 
characterize and study the biofilms formed on the materials; a technique that proved 412 
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useful.  However, in terms of biomass and thickness, COMSTAT was only able to 413 
quantify changes in bacteria which remained adherent to the material surface and 414 
were visualised by CLSM.  It was evident that biofilms infiltrate the dressing 415 
materials.  Ion milling of biofilms growing on the materials showed that this was 416 
evident in the aerogels used in this study.  Hence, the biomass and thickness data for 417 
the aerogels (being extremely porous) will have been substantially underestimated 418 
compared to those of the film (possessing no apparent pores for the biofilms to 419 
invade). 420 
Surface roughness plays a significant role in bacteria adhesion (Hsu, Fang, 421 
Borca-Tasciuc, Worobo & Moraru, 2013; Yoda et al., 2014).  This was confirmed in 422 
our study as the aerogel with the lowest surface roughness and porosity (A0.6) 423 
demonstrated the lowest biofilm growth (in terms of both thickness and biofilm 424 
height) and this was also markedly less than that observed on the commercial 425 
AquaCel® dressings.  Aerogels are likely to have a clinical advantage over the film for 426 
wound applications due to their enhanced absorbency; chronic wounds often 427 
producing large amounts of exudate.  This study showed that, despite having identical 428 
grammage, the aerogels (A0.2, A0.4 and A0.6) possessed distinctly different material 429 
properties (e.g. surface roughness, fluid absorption).  The commercial dressings 430 
AquaCel® and AquaCel Ag® displayed an inherently rough surface, which 431 
progressively altered during the course of the experiment to become smoother with 432 
increased absorption of fluids as noted by Walker, Hobot, Newman & Bowler (2003).   433 
Our results indicate an ability to fabricate the desired surface/pore structure of 434 
the CNF materials and their absorbance, which will be important in distinct clinical 435 
applications.  For example, wound dressings should have a smooth surface (to reduce 436 
bacterial adhesion), with adequate porosity to enhance absorbency (and retain wound 437 
fluid), whilst maintaining a moist environment to promote healing.  These 438 
microbiological studies show the potential use of CNF as a wound dressing material.  439 
Not only was it demonstrated that CNF dispersions did not support bacterial growth 440 
but, when the CNF dispersions were challenged with P. aeruginosa PAO1, bacterial 441 
growth was inhibited.  Using CNF as a potential wound dressing material represents 442 
an important clinical use for this sustainable resource, with properties comparable to 443 
those of commercially-available dressings. 444 
 445 
5. Conclusions   446 
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Our previous studies have importantly shown these materials to be non-toxic to 447 
human cells.  This study confirms that CNF produced using differing manufacturing 448 
processes generates a potential wound dressing material, which allows for absorbency 449 
based on porosity to be controlled.  Bacterial virulence was unaltered when grown on 450 
these materials, showing equivalency with other commercially available wound 451 
dressings already on the market.  Moreover, these materials are biodegradable and 452 
may be renewably sourced; both of which are important for biosustainability.  Also as 453 
the physical and chemical composition of CNF is highly malleable, the development 454 
of nanocellulose dressings offers significant clinical potential. 455 
 456 
 457 
ASSOCIATED CONTENT 458 
Supporting Information 459 
Growth characteristics for P. aeruginosa PAO1 in CNF; Absorbancy of the CNF 460 
materials used in this study; CLSM images and COMSTAT analysis of 461 
LIVE/DEAD® staining of 48 h biofilms grown on CNF aerogels; and SEM images of 462 
24 and 48 h P. aeruginosa PAO1 biofilms grown on the CNF materials.   463 
 464 
Acknowledgements  465 
We thank the Norwegian Micro- and Nano-Fabrication Facility for the AFM and 466 
STEM analyses (Grant no. 197411/V30).  This work was funded by the Research 467 
Council of Norway through the NANO2021 program, (Grant no. 219733) – 468 
NanoHeal: Bio-compatible cellulose nanostructures for advanced wound healing 469 
applications.  470 
 471 
 472 
References 473 
Adonizio, A., Kong, K-F., & Mathee, K. (2008). Inhibition of quorum sensing-474 
controlled virulence factor production in Pseudomonas aeruginosa by south 475 
Florida plant extracts. Antimicrobrobial Agents & Chemotherapy, 52(1), 198–203. 476 
Alexandresku, L., Syverud, K., Gatti, A. & Chinga-Carrasco, G. (2013). Cytotoxicity 477 
tests of cellulose nanofibril-based structures. Cellulose, 20(4), 1765-1775. 478 
Beal, R., & Betts, W. B. (2000). Role of rhamnolipid biosurfactants in the uptake and 479 
mineralization of hexadecane in Pseudomonas aeruginosa. Journal of Applied 480 
Submitted to Carbohydrate polymers. Last update 15.08.2016. 
18 
 
Microbiology, 89(1), 158-168.  481 
Bjarnsholt, T., Kirketerp-Møller, K., Jensen, P.Ø., Madsen, KG., Phipps, R., Krogfelt, 482 
K., Høiby, N., & Givskov, M. (2008). Why chronic wounds will not heal: a novel 483 
hypothesis. Wound Repair & Regeneration, 16(1), 2-10. 484 
Caballero, A. R., Moreau, J. M., Engel, L. S., Marquart, M. E., Hill, J. M., & 485 
O’Callaghan, R. (2001). Pseudomonas aeruginosa protease IV enzyme assays and 486 
comparison to other Pseudomonas proteases. Analytical Biochemistry, 290(2), 487 
330–337. 488 
Chinga-Carrasco, G., Yu, Y., & Diserud, O. (2011). Quantitative electron microscopy 489 
of cellulose nanofibril structures from Eucalyptus and Pinus radiata kraft pulp 490 
fibres. Microscopy & Microanalysis, 17(4), 563-571.  491 
Chinga-Carrasco, G., & Syverud, K. (2014). Pretreatment-dependent surface 492 
chemistry of wood nanocellulose for pH-sensitive hydrogels. Journal of 493 
Biomaterials Applications, 29(3), 423-432. 494 
Chinga-Carrasco, G., Kuznetsova, N., Garaeva, M., Leirset, I., Galiullina, G., 495 
Kostochko, A., & Syverud, K. (2012). Bleached and unbleached MFC nanobarriers 496 
- properties and hydrophobization with hexamethyldisilazane. Journal of 497 
Nanoparticle Research, 14(12), 1-10. 498 
Czaja, W., Krystynowicz, A., Bielecki, S., & Brown Jr, R. M. (2006). Microbial 499 
cellulose—the natural power to heal wounds. Biomaterials, 27(2), 145-151. 500 
Davies, CE., Hill, KE., Wilson, MJ., Stephens, P., Hill, CM., Harding, KG., & 501 
Thomas, DW. (2004). Use of 16S ribosomal DNA PCR and denaturing gradient 502 
gel electrophoresis for analysis of the microfloras of healing and nonhealing 503 
chronic venous leg ulcers. Journal of Clinical Microbiology, 42(8), 3549-3557 504 
Fukuzumi, H., Saito, T., Iwata, T., Kumamoto, Y., & Isogai, A. (2009). Transparent 505 
and high gas barrier films of cellulose nanofibers prepared by TEMPO-mediated 506 
oxidation. Biomacromolecules 10(1), 162–165. 507 
Fulton, J. A., Blasiole, K. N., Cottingham, T., Tornero, M., Graves, M., Smith, L. G., 508 
Mirza, S., & Mostow, E. N. (2012). Wound dressing absorption: A comparative 509 
study. Advances in Skin Wound Care, 25(7), 315-320. 510 
Heydorn, A., Nielsen, A. T., Hentzer, M., Sternberg, C., Givskov, M., Ersbøll, B. K., 511 
& Molin, S. (2000). Quantification of biofilm structures by the novel computer 512 
program COMSTAT.  Microbiology, 146(10), 2395–2407.  513 
Submitted to Carbohydrate polymers. Last update 15.08.2016. 
19 
 
Hill, K.E., Malic, S., McKee, R., Rennison, T., Harding, K.G., Williams, D.W., & 514 
Thomas, D.W. (2010). An in vitro model of chronic wound biofilms to test wound 515 
dressings and assess antimicrobial susceptibilities. Journal of Antimicrobial 516 
Chemotherapy 65(6), 1195-1206. 517 
Hsu, L. C., Fang, J., Borca-Tasciuc, D. A., Worobo, R. W., & Moraru, C. I. (2013). 518 
Effect of micro- and nanoscale topography on the adhesion of bacterial cells to 519 
solid surfaces. Applied & Environmental Microbiology 2013, 79(8), 2703–2712. 520 
Hua, K., Ålander, E., Lindstr̈m, T., Mihranyan, A., Strømme, M., & Ferraz, N. 521 
(2015). Surface chemistry of nanocellulose fibers directs monocyte/macrophage 522 
response.  Biomacromolecules, 16(9), 2787−2795. 523 
Isogai, A., Saito, T., & Fukuzumi, H. (2011). TEMPO-oxidized cellulose nanofibers. 524 
Nanoscale, 3(1), 71-85. 525 
Jung, K., Covington, S., Sen, S. K., Januszyk, M., Kirsner, R. S., Gurtner, G. C., & 526 
Shah, N. H. (2016). Rapid identification of slow healing wounds. Wound Repair & 527 
Regeneration, 24(1),181-188. 528 
Kolakovic, R,, Peltonen, L., Laaksonen, T., Putkisto, K., Laukkanen, A., & Hirvonen 529 
(2011). Spray-dried cellulose nanofibers as novel tablet excipient. J. AAPS 530 
PharmSciTech., 12(4), 1366–1312. 531 
Lau, G. W., Hassett, D. J., Ran, H., & Kong, F. (2004). The role of pyocyanin in 532 
Pseudomonas aeruginosa infection. Trends in Molecular Medicine, 10(12), 599-533 
606. 534 
Lin, N. & Dufresne, A. (2014). Nanocellulose in biomedicine: Current status and 535 
future prospect. European Polymer Journal 59, 302–325. 536 
Lou, Y. R., Kanninen, L., Kuisma, T., Niklander, J., Noon, L. A., Burks, D., Urtti, A., 537 
& Yliperttula, M. (2014). The use of nanofibrillar cellulose hydrogel as a flexible 538 
three-dimensional model to culture human pluripotent stem cells. Stem Cells & 539 
Development, 23(4), 380−392. 540 
Mogoşanu, G. D., & Grumezescu, A. M. (2014). Natural and synthetic polymers for 541 
wounds and burns dressing. International Journal of Pharmaceutics, 463(2), 127-542 
136. 543 
Ninan, N., Muthiah, M., Park, I-K., Elain, A., Thomas, S., & Grohens, Y. (2013). 544 
Pectin/carboxymethyl cellulose/microfibrillated cellulose composite scaffolds for 545 
tissue engineering. Carbohydrate Polymers, 98, 877–98. 546 
Submitted to Carbohydrate polymers. Last update 15.08.2016. 
20 
 
Nordli, H. R., Chinga-Carrasco, G., Rokstad, A. M., & Pukstad, B. (2016). Producing 547 
ultrapure wood cellulose nanofibrils and evaluating the cytotoxicity using human 548 
skin cells. Carbohydrate Polymers, DOI:10.1016/j.carbpol.2016.04.094. 549 
Oldak, E., & Trafny, E.A. (2005). Secretion of proteases by Pseudomonas aeruginosa 550 
biofilms exposed to ciprofloxacin. Antimicrobial Agents & Chemotherapy, 49(8), 551 
3281-3288.  552 
Ong, S-Y., Wu, J., Moochhala, S. M., Tan, M. H., & Lu, J. (2008). Development of a 553 
chitosan-based wound dressing with improved hemostatic and antimicrobial 554 
properties. Biomaterials, 29(32), 4323–4332. 555 
Percival, S. L., Hill, K. E., Williams, D. W., Hooper, S. J., Thomas, D. W., & 556 
Costerton, J. W. (2012). A review of the scientific evidence for biofilms in 557 
wounds. Wound Repair Regeneration, 20(5), 647–657. 558 
Petersen, N., & Gatenholm, P. (2011). Bacterial cellulose-based materials and 559 
medical devices: current state and perspectives. Applied Microbiology & 560 
Biotechnology, 91(5), 1277-1286. 561 
Portal, O., Clark, W. A., & Levinson, D. J. (2009). Microbial cellulose wound 562 
dressing in the treatment of nonhealing lower extremity ulcers. Wounds, 21(1), 1-3. 563 
Powell, L. C., Khan, S., Chinga-Carrasco, G., Wright, C. J., Hill, K. E., & Thomas, D. 564 
W. (2016). An investigation of Pseudomonas aeruginosa biofilm growth on novel 565 
nanocellulose fibre dressings. Carbohydrate Polymers, 137, 191-197. 566 
Ran, H., Hassett, D. J., & Lau, G. W. (2003). Human targets of Pseudomonas 567 
aeruginosa pyocyanin. Proceedings of the National Academy of Sciences, USA, 568 
100(24), 14315–14320. 569 
Rees, A., Powell, LC., Chinga-Carrasco, G., Gethin, DT., Syverud, K., Hill, KE., & 570 
Thomas, DW. (2015). 3D Bioprinting of carboxymethylated-periodate oxidized 571 
nanocellulose constructs for wound dressing applications. BioMed Research 572 
International, 2015, 925757. 573 
Saito, T., & Isogai, A. (2004). TEMPO-mediated oxidation of native cellulose. the 574 
effect of oxidation conditions on chemical and crystal structures of the water-575 
insoluble fractions. Biomacromolecules, 5(5), 1983–1989. 576 
Saito, T., Nishiyama, Y., Putaux, JL., Vignon, M., & Isogai, A. (2006). Homogeneous 577 
suspensions of individualized microfibrils from TEMPO-catalyzed oxidation of 578 
native cellulose. Biomacromolecules, 7(6), 1687-1691. 579 
Sampedro, I., Parales, R. E., Krell, T., & Hill, J. E. (2015). Pseudomonas chemotaxis. 580 
Submitted to Carbohydrate polymers. Last update 15.08.2016. 
21 
 
FEMS Microbiology Reviews, 39, 17-46. 581 
Sarabhai, S., Sharma, P., & Capalash, N. (2013). Ellagic acid derivatives from 582 
Terminalia chebula Retz. downregulate the expression of quorum sensing genes to 583 
attenuate Pseudomonas aeruginosa PAO1 virulence. PLoS One, 8(1), e53441  584 
Smyth, T. J. P., Perfumo, A., McClean, S., Marchant, R., & Banat, I. M.  (2010). In: 585 
K. N. Timmis (Ed.), Handbook of Hydrocarbon and Lipid Microbiology (pp. 3689-586 
3704) Heidelberg: Springer-Verlag.  587 
Soberón-Chávez, G., Lépine, F., & Déziel, E. (2005). Production of rhamnolipids by 588 
Pseudomonas aeruginosa. Appl. Microbiol. Biotechnol., 68(6), 718–725. 589 
Sorensen, R. U., & Klinger, J. D. (1987). Biological effects of Pseudomonas 590 
aeruginosa phenazine pigments. Antibiotic Chemotherapy, 39, 113–124. 591 
Syverud, K., Kirsebom, H., Hajizadeh, S., & Chinga-Carrasco, G. (2011). Cross-592 
linking cellulose nanofibrils for potential elastic cryo-structured gels. Nanoscale 593 
Research Letters 6, 626. 594 
Tehrani, Z., Nordli, H. R., Pukstad, B., Gethin, D.T., & Chinga-Carrasco, G. (2016).  595 
Translucent and ductile nanocellulose-PEG bionanocomposites – a novel substrate 596 
with potential to be functionalized by printing for wound dressing applications. 597 
Industrial Crops & Products,  DOI:10.1016/j.indcrop.2016.02.024. 598 
Walker, M., Hobot, JA., Newman, GR., & Bowler, PG. (2003). Scanning electron 599 
microscopic examination of bacterial immobilisation in a carboxymethyl cellulose 600 
(AQUACEL) and alginate dressings. Biomaterials, 24(5), 883-890. 601 
Wågberg, L., Decher, G., Norgren, M., Lindström, T., Ankerfors, M., & Axnäs, K. 602 
(2008). The build-up of polyelectrolyte multilayers of microfibrillated cellulose 603 
and cationic polyelectrolytes. Langmuir, 24(3), 784–795. 604 
Yoda, I., Koseki, H., Tomita, M., Shida, T., Horiuchi, H., Sakoda, H., & Osaki, M.  605 
(2014). Effect of surface roughness of biomaterials on Staphylococcus epidermidis 606 
adhesion. BMC Microbiology, 14, 234.   607 
